The Polish Medical Devices Act of 7 April 2022 (the MDA) imposes certain restrictions on the medical device advertising that is addressed to the general public. Such advertising activities must not be misleading (Article 7 of the MDR or the IVDR, and Article 55(3) of the MDA), but also must not:

It’s been four years since we sat down with Octavian Popescu, Managing Partner at Popescu & Asociatii, and discussed what was at that time the new firm’s perspective and its future plans. We reached out again, on the firm’s Fourth Anniversary, to see how those plans have been progressing and chart the firm’s development.

The EU regulations (Regulations 2017/745 on medical devices (the MDR) and 2017/746 on in vitro diagnostic medical devices (the IVDR)), introduced a prohibition of misleading advertising of medical devices.

Gessel has advised private equity fund EMSA Capital on the full sale of Famed Zywiec to Czech fund BHM Group. Wolf Theiss advised the buyer.

B2RLaw has advised DocPlanner on its acquisition of MyDr. LSW Lesnodorski Slusarek & Partners advised the sellers.

Kinstellar Croatian affiliate Zuric i Partneri has advised OTP Banka on the financing for Adria Dental Group’s acquisition of the Fiziodent Polyclinic. Batarelo Dvojkovic Vuchetich advised the Adria Dental Group on the acquisition and financing. Kramaric & Partners advised Karlo Sudarevic on the sale.